Seres Therapeutics, Inc. Fair Value, Assets, Level 1 to Level 2 Transfers, Amount
Seres Therapeutics, Inc. (MCRB) had Fair Value, Assets, Level 1 to Level 2 Transfers, Amount of $0 as of 2022-03-31, per its 10-Q filed 2022-05-04.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount · last filed 2022-05-04
- 2022-03-31: Fair Value, Assets, Level 1 to Level 2 Transfers, Amount $0.00.
- 2021-12-31: Fair Value, Assets, Level 1 to Level 2 Transfers, Amount $0.00.
- 2021-09-30: Fair Value, Assets, Level 1 to Level 2 Transfers, Amount $0.00.
- 2021-06-30: Fair Value, Assets, Level 1 to Level 2 Transfers, Amount $0.00.
| Period end | Fair Value, Assets, Level 1 to Level 2 Transfers, Amount |
|---|---|
| 2022-03-31 | $0.00 10-Q · filed 2022-05-04 |
| 2021-12-31 | $0.00 10-K · filed 2022-03-01 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-10 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-03 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-04 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-01 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-10 |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-03 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-07 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-02 |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-09 |
| 2019-06-30 | $0.00 10-Q · filed 2020-07-28 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-02 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-08 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-02 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-09 |
| 2017-12-31 | $0.00 10-K · filed 2018-03-08 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-08 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-03 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-04 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-08 |
| 2016-09-30 | $0.00 10-Q · filed 2017-11-08 |
| 2016-06-30 | $0.00 10-Q · filed 2017-08-03 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-16 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-16 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-12 |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-10 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-14 |
| 2014-09-30 | $0.00 10-Q · filed 2015-11-12 |
| 2014-06-30 | $0.00 10-Q · filed 2015-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |